Acute Respiratory Failure in the Patient with Cancer: Diagnostic and Management Strategies
Section snippets
Causes of ARF in patients with cancer
The myriad causes of ARF in critically ill patients with cancer are listed in Table 1. The most frequent causes include pulmonary infections (pneumonia), cardiogenic and noncardiogenic pulmonary edema (ALI/acute respiratory distress syndrome [ARDS]), antineoplastic therapy (chemotherapy, radiation therapy)-induced lung injury, cancer-related medical disorders (such as venous thromboembolism [VTE] and diffuse alveolar hemorrhage [DAH]), direct involvement of the respiratory system by malignancy
Pneumonia
Pulmonary infections are the most common cause of ARF in patients with cancer, especially in those with significant comorbidities (eg, chronic obstructive pulmonary disease, cardiac failure), underlying hematologic malignancies, and in those receiving chemotherapy.34, 35, 36 Several factors increase the risk of infection in these patients, including defects in humoral or cell-mediated immunity, neutropenia, use of corticosteroids, frequent exposure to antibiotics, and prolonged hospitalization.
ALI and ARDS
ALI is a clinical syndrome characterized by the acute onset of severe hypoxemia (as defined by a ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen [Pao2/Fio2] <300) and the presence of bilateral alveolar or interstitial infiltrates in the absence of congestive heart failure.55 ARDS is a more severe form of lung injury defined by a Pao2/Fio2 ratio less than 200. Atypical presentation of ARDS with unilateral infiltrates on chest radiograph is noteworthy,
Antineoplastic agent-induced lung injury
Pulmonary toxicity from antineoplastic agents is an important cause of respiratory failure in patients who have cancer. The various clinical syndromes associated with antineoplastic-induced lung injury include acute interstitial pneumonitis, ALI/ARDS, capillary leak syndrome, organizing pneumonia, hypersensitivity reaction, bronchospasm, and DAH. A listing of the most common chemotherapeutic and immunosuppressive agents associated with pulmonary toxicity can be found at http://www.pneumotox.com
VTE
VTE, manifested as either deep venous thrombosis (DVT) or pulmonary embolism (PE), remains an important and major cause of morbidity and mortality in patients with cancer.90, 91 When adjusted for disease prevalence, the malignancies most strongly associated with thrombotic complications are those of the pancreas, ovary, and brain.92 Several factors or conditions increase the risk for DVT and PE in patients with cancer, including intrinsic tumor procoagulant activity, antineoplastic drugs (such
DAH
Alveolar hemorrhage is a frequent cause of respiratory failure in thrombocytopenic patients (platelet counts <50,000/mm3) with acute or chronic leukemias or multiple myeloma. The incidence of DAH in recipients of hematopoietic stem cell transplantation ranges from 2% to 12%.110, 111 Pretransplant intensive chemotherapy, including conditioning regimen, total body irradiation, thoracic irradiation, and old age, are known risk factors for DAH.110 The pathogenesis of DAH in HSCT recipients is
Transfusion-related acute lung injury (TRALI)
Patients with cancer, particularly those with hematologic malignancies and patients undergoing major cancer surgery, frequently require transfusion of fresh frozen plasma, platelets, and packed red blood cells, and thus are susceptible to TRALI. This syndrome usually takes the form of noncardiogenic pulmonary edema and is commonly associated with fever, hypotension, severe hypoxemia, pulmonary hypertension, and bilateral lung infiltrates with normal left ventricular function.116 Similarly,
Radiation-induced lung injury
Radiation-induced lung injury is generally limited to the irradiated lung volume and results in several histopathologic changes, including enlargement and atypia of type II pneumocytes, alveolar wall edema, infiltration of the interstitium by monocytes and fibroblasts, aggregation of alveolar macrophages, and dense collagen fibrosis.119 Significant lung injury from radiation therapy is dependent on the volume of lung irradiated, the total dose, and the dose per fraction used. Although radiation
Paraneoplastic syndromes
Approximately 30% of patients with thymomas develop myasthenia gravis and often the respiratory failure worsens around the time of thymectomy. The diagnosis is confirmed with the finding of improvement in muscle strength after the administration of IV edrophonium (Tensilon) and evidence of decremental response of the muscle action potential to repetitive nerve testing on electromyogram (EMG) studies. Supportive measures, in addition to cholinesterase inhibitors such as pyridostigmine and
Management principles for ARF in the critical care setting
The key management principles for cancer patients who develop ARF include a comprehensive diagnostic work-up including fiberoptic bronchoscopy to identify the cause of the respiratory failure; appropriate and timely use of antimicrobial therapy in those with infectious disorders; and respiratory support including early use of NIPPV rather than invasive MV. The reader is referred to a flow-chart outlining the recommendations for selecting the initial ventilatory strategy in cancer patients with
Prognosis and outcome data
Although MV remains an important life-support modality for many patients who have cancer with ARF, these patients generally have survival rates less than 20%.1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 In recent years, however, there has been optimism about improved survival rates in mechanically ventilated patients with cancer.7, 17
In addition to general ICU mortality prediction models (eg, Acute Physiology and Chronic Health Evaluation [APACHE] II and III, Mortality Probability Models,
Summary
The diagnosis and management of ARF in patients with cancer poses special challenges to the intensivist. The clinical presentation of ARF in patients with cancer may be less specific than in patients without cancer. Depending on the type of cancer, the degree of immunosuppression, underlying comorbidities, and the modality of cancer treatment, progression or spread of underlying cancer, and disease- or therapy-associated complications are the most common causes of ARF in these patients. Despite
References (136)
- et al.
Outcome of respiratory failure in hematologic malignancy
Chest
(1988) - et al.
Outcome and code status of lung cancer patients admitted to the medical ICU
Chest
(2006) - et al.
Precedents for meaningful recovery during treatment in a medical intensive care unit. Outcome in patients with hematologic malignancy
Am J Med
(1983) - et al.
Outcome of recipients of bone marrow transplants who require intensive-care unit support
Mayo Clin Proc
(1992) - et al.
Outcome of patients requiring medical ICU admission following bone marrow transplantation
Chest
(1993) - et al.
Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation
Blood
(2001) Acute respiratory failure in critically ill patients with cancer. Diagnosis and management
Crit Care Clin
(2001)- et al.
Modern thirty-day operative mortality for surgical resections in lung cancer
J Thorac Cardiovasc Surg
(1983) - et al.
Induction chemoradiotherapy increases pleural and pericardial complications after esophagectomy for cancer
J Thorac Oncol
(2009) - et al.
Pneumonia in the compromised host including cancer patients and transplant patients
Infect Dis Clin North Am
(1998)
Lung infections after cancer chemotherapy
Lancet Oncol
Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review
J Hosp Infect
Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL
Respir Med
Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients
Chest
Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates
Chest
Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies
Biol Blood Marrow Transplant
Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome
Blood
Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection
Blood
Pulmonary infiltrates in the non-HIV-infected immunocompromised patient: etiologies, diagnostic strategies, and outcomes
Chest
Epidemiology of acute lung injury and acute respiratory distress syndrome in The Netherlands: a survey
Respir Med
Epidemiology and outcomes of acute lung injury
Chest
Acute lung injury and acute respiratory distress syndrome after pulmonary resection
Ann Thorac Surg
Prevalence and mortality of acute lung injury and ARDS after lung resection
Chest
Adult respiratory distress syndrome in neutropenic patients
Am J Med
Less is more: improved outcomes in surgical patients with conservative fluid administration and central venous catheter monitoring
J Am Coll Surg
Mortality rates for patients with acute lung injury/ARDS have decreased over time
Chest
Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial
Lancet
Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial
Lancet
Pulmonary complications of novel antineoplastic agents for solid tumors
Chest
Bleeding and thrombotic complications in critically ill patients with cancer
Crit Care Clin
PIOPED II investigators. Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II investigators
Am J Med
Management of venous thromboembolism in the intensive care unit
J Crit Care
Survival of patients with cancer in a medical critical care unit
Arch Intern Med
Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit
Crit Care Med
The prognosis of acute respiratory failure in critically ill cancer patients
Medicine (Baltimore)
Characteristics and outcomes of cancer patients requiring mechanical ventilatory support for >24 hrs
Crit Care Med
Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication
Crit Care Med
Respiratory failure in cancer patients
JAMA
Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy
Crit Care Med
Outcome of lung cancer patients requiring mechanical ventilation for pulmonary failure
JAMA
Prognosis of patients receiving intensive care for life-threatening medical complications of haematological malignancy
Br Med J (Clin Res Ed)
Acute respiratory failure in severe hematologic disorders
Crit Care Med
Outcome for cancer patients requiring mechanical ventilation
J Clin Oncol
Incidence and prognostic value of respiratory events in acute leukemia
Leukemia
Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure
N Engl J Med
Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support
Crit Care Med
Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines
Ann Intern Med
Outcome of bone marrow transplantation patients requiring mechanical ventilation
Crit Care Med
Survival of adult bone marrow transplant patients receiving mechanical ventilation: a case for restricted use
Bone Marrow Transplant
Efficacy of intensive care for bone marrow transplant patients with respiratory failure
Crit Care Med
Cited by (43)
Colombian consensus of criteria for intensive care admission: Task force of the Colombian Association of Critical Medicine and Intensive Care (AMCI®)
2023, Acta Colombiana de Cuidado IntensivoTriage and Prognostication of Cancer Patients Admitted to the Intensive Care Unit
2021, Critical Care ClinicsCitation Excerpt :It usually is associated with poor outcome, especially if mechanical ventilation is needed in the setting of acute respiratory distress syndrome (ARDS).43,45–47 The mortality risk with invasive mechanical ventilation (IMV) is disproportionately high.48,49 A multicenter study of 1004 patients with solid or hematological malignancies found that mortality associated with ARDS is high at 52%.45
Critical Care Prognosis and Outcomes in Patients with Cancer
2017, Clinics in Chest MedicineCitation Excerpt :Furthermore, there is evidence that admitting high-risk patients to receive chemotherapy in the ICU may result in better outcomes and fewer complications, given the high-quality care and close monitoring in this environment.70 Acute respiratory failure (ARF) develops in 10% to 50% of patients with cancer and is an important cause of admission to the ICU in this patient population.73 Invasive mechanical ventilation for ARF has been associated traditionally with a high mortality, exceeding 90%.10,11,62
Critically ill patients with cancer: Chances and limitations of intensive care medicine - A narrative review
2016, ESMO OpenCitation Excerpt :Finally, all patients with cancer had higher mortality rates in case of ≥3 organ failures when compared to patients without cancer (75% vs 50%).3 The occurrence of acute respiratory failure (ARF) is the most important risk factor to die for critically ill patients with cancer.7 In fact, mortality is already increased in patients requiring oxygen insufflation at a rate of 1 L/min only and disproportionately increases if invasive mechanical ventilation (IMV) becomes necessary.8
High-value care for critically ill oncohematological patients: what do we know thus far?
2023, Critical Care Science
Conflict of Interest: None.
Financial Support: None.